nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—Rivastigmine—Alzheimer's disease	0.58	1	CrCtD
Tapentadol—HTR3A—Memantine—Alzheimer's disease	0.0995	0.556	CbGbCtD
Tapentadol—SLC6A4—Alzheimer's disease	0.0875	0.587	CbGaD
Tapentadol—CYP2D6—Alzheimer's disease	0.0615	0.413	CbGaD
Tapentadol—CYP2D6—Rivastigmine—Alzheimer's disease	0.0194	0.108	CbGbCtD
Tapentadol—CYP2C19—Memantine—Alzheimer's disease	0.0177	0.0988	CbGbCtD
Tapentadol—CYP2C9—Donepezil—Alzheimer's disease	0.017	0.0947	CbGbCtD
Tapentadol—CYP2D6—Donepezil—Alzheimer's disease	0.0155	0.0866	CbGbCtD
Tapentadol—CYP2D6—Galantamine—Alzheimer's disease	0.00999	0.0558	CbGbCtD
Tapentadol—SLC6A2—locus ceruleus—Alzheimer's disease	0.00257	0.18	CbGeAlD
Tapentadol—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00166	0.116	CbGeAlD
Tapentadol—OPRD1—forebrain—Alzheimer's disease	0.000637	0.0445	CbGeAlD
Tapentadol—Edrophonium—ACHE—Alzheimer's disease	0.000619	0.297	CrCbGaD
Tapentadol—OPRK1—forebrain—Alzheimer's disease	0.000611	0.0427	CbGeAlD
Tapentadol—OPRD1—telencephalon—Alzheimer's disease	0.000586	0.041	CbGeAlD
Tapentadol—Rivastigmine—ACHE—Alzheimer's disease	0.000575	0.276	CrCbGaD
Tapentadol—HTR3A—forebrain—Alzheimer's disease	0.000474	0.0331	CbGeAlD
Tapentadol—HTR3A—telencephalon—Alzheimer's disease	0.000436	0.0305	CbGeAlD
Tapentadol—OPRM1—forebrain—Alzheimer's disease	0.000435	0.0304	CbGeAlD
Tapentadol—OPRM1—telencephalon—Alzheimer's disease	0.0004	0.0279	CbGeAlD
Tapentadol—Edrophonium—BCHE—Alzheimer's disease	0.000364	0.175	CrCbGaD
Tapentadol—SLC6A4—forebrain—Alzheimer's disease	0.000362	0.0253	CbGeAlD
Tapentadol—OPRD1—nervous system—Alzheimer's disease	0.000346	0.0242	CbGeAlD
Tapentadol—Rivastigmine—BCHE—Alzheimer's disease	0.000338	0.163	CrCbGaD
Tapentadol—OPRD1—central nervous system—Alzheimer's disease	0.000333	0.0233	CbGeAlD
Tapentadol—SLC6A4—telencephalon—Alzheimer's disease	0.000332	0.0232	CbGeAlD
Tapentadol—OPRK1—nervous system—Alzheimer's disease	0.000332	0.0232	CbGeAlD
Tapentadol—OPRK1—central nervous system—Alzheimer's disease	0.000319	0.0223	CbGeAlD
Tapentadol—SLC6A2—forebrain—Alzheimer's disease	0.000318	0.0222	CbGeAlD
Tapentadol—OPRK1—cerebellum—Alzheimer's disease	0.000312	0.0218	CbGeAlD
Tapentadol—SLC6A2—telencephalon—Alzheimer's disease	0.000293	0.0205	CbGeAlD
Tapentadol—OPRD1—brain—Alzheimer's disease	0.000264	0.0185	CbGeAlD
Tapentadol—HTR3A—nervous system—Alzheimer's disease	0.000257	0.018	CbGeAlD
Tapentadol—OPRK1—brain—Alzheimer's disease	0.000254	0.0177	CbGeAlD
Tapentadol—HTR3A—central nervous system—Alzheimer's disease	0.000248	0.0173	CbGeAlD
Tapentadol—OPRM1—nervous system—Alzheimer's disease	0.000236	0.0165	CbGeAlD
Tapentadol—OPRM1—central nervous system—Alzheimer's disease	0.000227	0.0159	CbGeAlD
Tapentadol—Irritability—Memantine—Alzheimer's disease	0.000226	0.00404	CcSEcCtD
Tapentadol—Visual impairment—Galantamine—Alzheimer's disease	0.000224	0.00401	CcSEcCtD
Tapentadol—Ataxia—Memantine—Alzheimer's disease	0.000222	0.00398	CcSEcCtD
Tapentadol—Ataxia—Rivastigmine—Alzheimer's disease	0.000218	0.00389	CcSEcCtD
Tapentadol—Eye disorder—Galantamine—Alzheimer's disease	0.000217	0.00389	CcSEcCtD
Tapentadol—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000216	0.00386	CcSEcCtD
Tapentadol—Cardiac disorder—Galantamine—Alzheimer's disease	0.000216	0.00386	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000213	0.00381	CcSEcCtD
Tapentadol—Nasopharyngitis—Memantine—Alzheimer's disease	0.000212	0.00378	CcSEcCtD
Tapentadol—Angiopathy—Galantamine—Alzheimer's disease	0.000211	0.00377	CcSEcCtD
Tapentadol—Immune system disorder—Galantamine—Alzheimer's disease	0.00021	0.00376	CcSEcCtD
Tapentadol—Breast disorder—Rivastigmine—Alzheimer's disease	0.000209	0.00374	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000209	0.00373	CcSEcCtD
Tapentadol—Pollakiuria—Donepezil—Alzheimer's disease	0.000208	0.00372	CcSEcCtD
Tapentadol—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000207	0.0037	CcSEcCtD
Tapentadol—Mental disorder—Galantamine—Alzheimer's disease	0.000204	0.00364	CcSEcCtD
Tapentadol—Weight decreased—Donepezil—Alzheimer's disease	0.000204	0.00364	CcSEcCtD
Tapentadol—Malnutrition—Galantamine—Alzheimer's disease	0.000203	0.00362	CcSEcCtD
Tapentadol—Infestation NOS—Donepezil—Alzheimer's disease	0.000201	0.00359	CcSEcCtD
Tapentadol—Infestation—Donepezil—Alzheimer's disease	0.000201	0.00359	CcSEcCtD
Tapentadol—Depression—Donepezil—Alzheimer's disease	0.0002	0.00358	CcSEcCtD
Tapentadol—Tension—Galantamine—Alzheimer's disease	0.000199	0.00355	CcSEcCtD
Tapentadol—HTR3A—brain—Alzheimer's disease	0.000197	0.0137	CbGeAlD
Tapentadol—Nervousness—Galantamine—Alzheimer's disease	0.000197	0.00352	CcSEcCtD
Tapentadol—SLC6A4—nervous system—Alzheimer's disease	0.000196	0.0137	CbGeAlD
Tapentadol—Urinary tract infection—Donepezil—Alzheimer's disease	0.000195	0.00349	CcSEcCtD
Tapentadol—Vision blurred—Galantamine—Alzheimer's disease	0.000191	0.00341	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00019	0.0034	CcSEcCtD
Tapentadol—Tremor—Galantamine—Alzheimer's disease	0.00019	0.00339	CcSEcCtD
Tapentadol—SLC6A4—central nervous system—Alzheimer's disease	0.000189	0.0132	CbGeAlD
Tapentadol—Pollakiuria—Memantine—Alzheimer's disease	0.000189	0.00338	CcSEcCtD
Tapentadol—Erectile dysfunction—Memantine—Alzheimer's disease	0.000188	0.00337	CcSEcCtD
Tapentadol—Agitation—Galantamine—Alzheimer's disease	0.000186	0.00333	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000186	0.00332	CcSEcCtD
Tapentadol—Rivastigmine—CYP2D6—Alzheimer's disease	0.000186	0.0892	CrCbGaD
Tapentadol—Weight decreased—Memantine—Alzheimer's disease	0.000185	0.00331	CcSEcCtD
Tapentadol—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000185	0.0033	CcSEcCtD
Tapentadol—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000184	0.00329	CcSEcCtD
Tapentadol—Bradycardia—Donepezil—Alzheimer's disease	0.000184	0.00328	CcSEcCtD
Tapentadol—Infestation—Memantine—Alzheimer's disease	0.000182	0.00326	CcSEcCtD
Tapentadol—Infestation NOS—Memantine—Alzheimer's disease	0.000182	0.00326	CcSEcCtD
Tapentadol—Vertigo—Galantamine—Alzheimer's disease	0.000182	0.00325	CcSEcCtD
Tapentadol—Depression—Memantine—Alzheimer's disease	0.000182	0.00325	CcSEcCtD
Tapentadol—Syncope—Galantamine—Alzheimer's disease	0.000182	0.00325	CcSEcCtD
Tapentadol—Weight decreased—Rivastigmine—Alzheimer's disease	0.000181	0.00324	CcSEcCtD
Tapentadol—OPRM1—brain—Alzheimer's disease	0.00018	0.0126	CbGeAlD
Tapentadol—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000179	0.00321	CcSEcCtD
Tapentadol—Hallucination—Donepezil—Alzheimer's disease	0.000179	0.00321	CcSEcCtD
Tapentadol—Palpitations—Galantamine—Alzheimer's disease	0.000179	0.0032	CcSEcCtD
Tapentadol—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000178	0.00319	CcSEcCtD
Tapentadol—Infestation—Rivastigmine—Alzheimer's disease	0.000178	0.00319	CcSEcCtD
Tapentadol—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000178	0.00318	CcSEcCtD
Tapentadol—Loss of consciousness—Galantamine—Alzheimer's disease	0.000178	0.00318	CcSEcCtD
Tapentadol—Depression—Rivastigmine—Alzheimer's disease	0.000178	0.00318	CcSEcCtD
Tapentadol—Urinary tract infection—Memantine—Alzheimer's disease	0.000177	0.00317	CcSEcCtD
Tapentadol—Urethral disorder—Donepezil—Alzheimer's disease	0.000177	0.00316	CcSEcCtD
Tapentadol—Cough—Galantamine—Alzheimer's disease	0.000177	0.00316	CcSEcCtD
Tapentadol—Convulsion—Galantamine—Alzheimer's disease	0.000175	0.00314	CcSEcCtD
Tapentadol—CYP2D6—forebrain—Alzheimer's disease	0.000174	0.0122	CbGeAlD
Tapentadol—Visual impairment—Donepezil—Alzheimer's disease	0.000174	0.00311	CcSEcCtD
Tapentadol—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000173	0.0031	CcSEcCtD
Tapentadol—SLC6A2—nervous system—Alzheimer's disease	0.000173	0.0121	CbGeAlD
Tapentadol—Arthralgia—Galantamine—Alzheimer's disease	0.000172	0.00308	CcSEcCtD
Tapentadol—Anxiety—Galantamine—Alzheimer's disease	0.000172	0.00307	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000171	0.00306	CcSEcCtD
Tapentadol—Dry mouth—Galantamine—Alzheimer's disease	0.000169	0.00301	CcSEcCtD
Tapentadol—Confusional state—Galantamine—Alzheimer's disease	0.000167	0.00298	CcSEcCtD
Tapentadol—Bradycardia—Memantine—Alzheimer's disease	0.000167	0.00298	CcSEcCtD
Tapentadol—SLC6A2—central nervous system—Alzheimer's disease	0.000166	0.0116	CbGeAlD
Tapentadol—Bradycardia—Rivastigmine—Alzheimer's disease	0.000163	0.00291	CcSEcCtD
Tapentadol—Hallucination—Memantine—Alzheimer's disease	0.000163	0.00291	CcSEcCtD
Tapentadol—Hypoaesthesia—Memantine—Alzheimer's disease	0.000163	0.00291	CcSEcCtD
Tapentadol—Shock—Galantamine—Alzheimer's disease	0.000163	0.00291	CcSEcCtD
Tapentadol—Nervous system disorder—Galantamine—Alzheimer's disease	0.000162	0.0029	CcSEcCtD
Tapentadol—Chills—Donepezil—Alzheimer's disease	0.000162	0.00289	CcSEcCtD
Tapentadol—Urinary tract disorder—Memantine—Alzheimer's disease	0.000162	0.00289	CcSEcCtD
Tapentadol—Tachycardia—Galantamine—Alzheimer's disease	0.000161	0.00288	CcSEcCtD
Tapentadol—Connective tissue disorder—Memantine—Alzheimer's disease	0.000161	0.00288	CcSEcCtD
Tapentadol—Skin disorder—Galantamine—Alzheimer's disease	0.000161	0.00287	CcSEcCtD
Tapentadol—Urethral disorder—Memantine—Alzheimer's disease	0.00016	0.00287	CcSEcCtD
Tapentadol—CYP2D6—telencephalon—Alzheimer's disease	0.00016	0.0112	CbGeAlD
Tapentadol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00016	0.00286	CcSEcCtD
Tapentadol—Hallucination—Rivastigmine—Alzheimer's disease	0.000159	0.00285	CcSEcCtD
Tapentadol—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000159	0.00285	CcSEcCtD
Tapentadol—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000158	0.00283	CcSEcCtD
Tapentadol—Mental disorder—Donepezil—Alzheimer's disease	0.000158	0.00282	CcSEcCtD
Tapentadol—Visual impairment—Memantine—Alzheimer's disease	0.000158	0.00282	CcSEcCtD
Tapentadol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000157	0.00281	CcSEcCtD
Tapentadol—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000157	0.00281	CcSEcCtD
Tapentadol—Malnutrition—Donepezil—Alzheimer's disease	0.000157	0.00281	CcSEcCtD
Tapentadol—Hypotension—Galantamine—Alzheimer's disease	0.000154	0.00276	CcSEcCtD
Tapentadol—Visual impairment—Rivastigmine—Alzheimer's disease	0.000154	0.00276	CcSEcCtD
Tapentadol—Tension—Donepezil—Alzheimer's disease	0.000154	0.00275	CcSEcCtD
Tapentadol—Eye disorder—Memantine—Alzheimer's disease	0.000153	0.00274	CcSEcCtD
Tapentadol—Nervousness—Donepezil—Alzheimer's disease	0.000152	0.00273	CcSEcCtD
Tapentadol—Cardiac disorder—Memantine—Alzheimer's disease	0.000152	0.00272	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000151	0.00269	CcSEcCtD
Tapentadol—SLC6A4—brain—Alzheimer's disease	0.00015	0.0105	CbGeAlD
Tapentadol—Eye disorder—Rivastigmine—Alzheimer's disease	0.00015	0.00268	CcSEcCtD
Tapentadol—Insomnia—Galantamine—Alzheimer's disease	0.000149	0.00267	CcSEcCtD
Tapentadol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000149	0.00266	CcSEcCtD
Tapentadol—Angiopathy—Memantine—Alzheimer's disease	0.000149	0.00266	CcSEcCtD
Tapentadol—Paraesthesia—Galantamine—Alzheimer's disease	0.000148	0.00265	CcSEcCtD
Tapentadol—Vision blurred—Donepezil—Alzheimer's disease	0.000148	0.00264	CcSEcCtD
Tapentadol—Immune system disorder—Memantine—Alzheimer's disease	0.000148	0.00264	CcSEcCtD
Tapentadol—Mediastinal disorder—Memantine—Alzheimer's disease	0.000148	0.00264	CcSEcCtD
Tapentadol—Tremor—Donepezil—Alzheimer's disease	0.000147	0.00263	CcSEcCtD
Tapentadol—Somnolence—Galantamine—Alzheimer's disease	0.000147	0.00263	CcSEcCtD
Tapentadol—Chills—Memantine—Alzheimer's disease	0.000147	0.00263	CcSEcCtD
Tapentadol—Dyspepsia—Galantamine—Alzheimer's disease	0.000145	0.0026	CcSEcCtD
Tapentadol—Angiopathy—Rivastigmine—Alzheimer's disease	0.000145	0.0026	CcSEcCtD
Tapentadol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000144	0.00258	CcSEcCtD
Tapentadol—Agitation—Donepezil—Alzheimer's disease	0.000144	0.00258	CcSEcCtD
Tapentadol—Chills—Rivastigmine—Alzheimer's disease	0.000144	0.00257	CcSEcCtD
Tapentadol—Decreased appetite—Galantamine—Alzheimer's disease	0.000144	0.00257	CcSEcCtD
Tapentadol—Mental disorder—Memantine—Alzheimer's disease	0.000143	0.00256	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000143	0.00255	CcSEcCtD
Tapentadol—Malnutrition—Memantine—Alzheimer's disease	0.000143	0.00255	CcSEcCtD
Tapentadol—Fatigue—Galantamine—Alzheimer's disease	0.000142	0.00255	CcSEcCtD
Tapentadol—Constipation—Galantamine—Alzheimer's disease	0.000141	0.00253	CcSEcCtD
Tapentadol—Vertigo—Donepezil—Alzheimer's disease	0.000141	0.00252	CcSEcCtD
Tapentadol—Syncope—Donepezil—Alzheimer's disease	0.000141	0.00252	CcSEcCtD
Tapentadol—Mental disorder—Rivastigmine—Alzheimer's disease	0.00014	0.00251	CcSEcCtD
Tapentadol—Tension—Memantine—Alzheimer's disease	0.00014	0.0025	CcSEcCtD
Tapentadol—Malnutrition—Rivastigmine—Alzheimer's disease	0.000139	0.00249	CcSEcCtD
Tapentadol—Nervousness—Memantine—Alzheimer's disease	0.000138	0.00247	CcSEcCtD
Tapentadol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000138	0.00247	CcSEcCtD
Tapentadol—Cough—Donepezil—Alzheimer's disease	0.000137	0.00245	CcSEcCtD
Tapentadol—Tension—Rivastigmine—Alzheimer's disease	0.000137	0.00245	CcSEcCtD
Tapentadol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000136	0.00244	CcSEcCtD
Tapentadol—Convulsion—Donepezil—Alzheimer's disease	0.000136	0.00243	CcSEcCtD
Tapentadol—Nervousness—Rivastigmine—Alzheimer's disease	0.000135	0.00242	CcSEcCtD
Tapentadol—Vision blurred—Memantine—Alzheimer's disease	0.000134	0.0024	CcSEcCtD
Tapentadol—Arthralgia—Donepezil—Alzheimer's disease	0.000134	0.00239	CcSEcCtD
Tapentadol—Tremor—Memantine—Alzheimer's disease	0.000134	0.00239	CcSEcCtD
Tapentadol—Anxiety—Donepezil—Alzheimer's disease	0.000133	0.00238	CcSEcCtD
Tapentadol—SLC6A2—brain—Alzheimer's disease	0.000132	0.00923	CbGeAlD
Tapentadol—Vision blurred—Rivastigmine—Alzheimer's disease	0.000131	0.00235	CcSEcCtD
Tapentadol—Agitation—Memantine—Alzheimer's disease	0.000131	0.00234	CcSEcCtD
Tapentadol—Dry mouth—Donepezil—Alzheimer's disease	0.000131	0.00234	CcSEcCtD
Tapentadol—Tremor—Rivastigmine—Alzheimer's disease	0.000131	0.00234	CcSEcCtD
Tapentadol—Confusional state—Donepezil—Alzheimer's disease	0.000129	0.00231	CcSEcCtD
Tapentadol—Agitation—Rivastigmine—Alzheimer's disease	0.000128	0.00229	CcSEcCtD
Tapentadol—Oedema—Donepezil—Alzheimer's disease	0.000128	0.00229	CcSEcCtD
Tapentadol—Vertigo—Memantine—Alzheimer's disease	0.000128	0.00229	CcSEcCtD
Tapentadol—Syncope—Memantine—Alzheimer's disease	0.000128	0.00228	CcSEcCtD
Tapentadol—Infection—Donepezil—Alzheimer's disease	0.000127	0.00228	CcSEcCtD
Tapentadol—Shock—Donepezil—Alzheimer's disease	0.000126	0.00225	CcSEcCtD
Tapentadol—Palpitations—Memantine—Alzheimer's disease	0.000126	0.00225	CcSEcCtD
Tapentadol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000126	0.00225	CcSEcCtD
Tapentadol—Vertigo—Rivastigmine—Alzheimer's disease	0.000125	0.00224	CcSEcCtD
Tapentadol—Loss of consciousness—Memantine—Alzheimer's disease	0.000125	0.00224	CcSEcCtD
Tapentadol—Syncope—Rivastigmine—Alzheimer's disease	0.000125	0.00224	CcSEcCtD
Tapentadol—Cough—Memantine—Alzheimer's disease	0.000124	0.00222	CcSEcCtD
Tapentadol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000124	0.00221	CcSEcCtD
Tapentadol—Convulsion—Memantine—Alzheimer's disease	0.000123	0.00221	CcSEcCtD
Tapentadol—Palpitations—Rivastigmine—Alzheimer's disease	0.000123	0.0022	CcSEcCtD
Tapentadol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000123	0.00219	CcSEcCtD
Tapentadol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000122	0.00218	CcSEcCtD
Tapentadol—Cough—Rivastigmine—Alzheimer's disease	0.000122	0.00217	CcSEcCtD
Tapentadol—Arthralgia—Memantine—Alzheimer's disease	0.000121	0.00217	CcSEcCtD
Tapentadol—Anxiety—Memantine—Alzheimer's disease	0.000121	0.00216	CcSEcCtD
Tapentadol—Convulsion—Rivastigmine—Alzheimer's disease	0.000121	0.00216	CcSEcCtD
Tapentadol—Hypotension—Donepezil—Alzheimer's disease	0.00012	0.00214	CcSEcCtD
Tapentadol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000119	0.00212	CcSEcCtD
Tapentadol—Dry mouth—Memantine—Alzheimer's disease	0.000119	0.00212	CcSEcCtD
Tapentadol—Asthenia—Galantamine—Alzheimer's disease	0.000119	0.00212	CcSEcCtD
Tapentadol—Anxiety—Rivastigmine—Alzheimer's disease	0.000118	0.00211	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000118	0.00211	CcSEcCtD
Tapentadol—Confusional state—Memantine—Alzheimer's disease	0.000117	0.0021	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000117	0.00209	CcSEcCtD
Tapentadol—Oedema—Memantine—Alzheimer's disease	0.000116	0.00208	CcSEcCtD
Tapentadol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000116	0.00208	CcSEcCtD
Tapentadol—Insomnia—Donepezil—Alzheimer's disease	0.000116	0.00207	CcSEcCtD
Tapentadol—Infection—Memantine—Alzheimer's disease	0.000116	0.00207	CcSEcCtD
Tapentadol—Paraesthesia—Donepezil—Alzheimer's disease	0.000115	0.00206	CcSEcCtD
Tapentadol—Confusional state—Rivastigmine—Alzheimer's disease	0.000115	0.00205	CcSEcCtD
Tapentadol—Shock—Memantine—Alzheimer's disease	0.000114	0.00205	CcSEcCtD
Tapentadol—Dyspnoea—Donepezil—Alzheimer's disease	0.000114	0.00204	CcSEcCtD
Tapentadol—Nervous system disorder—Memantine—Alzheimer's disease	0.000114	0.00204	CcSEcCtD
Tapentadol—Somnolence—Donepezil—Alzheimer's disease	0.000114	0.00204	CcSEcCtD
Tapentadol—Oedema—Rivastigmine—Alzheimer's disease	0.000114	0.00203	CcSEcCtD
Tapentadol—Tachycardia—Memantine—Alzheimer's disease	0.000114	0.00203	CcSEcCtD
Tapentadol—Diarrhoea—Galantamine—Alzheimer's disease	0.000113	0.00202	CcSEcCtD
Tapentadol—Infection—Rivastigmine—Alzheimer's disease	0.000113	0.00202	CcSEcCtD
Tapentadol—Skin disorder—Memantine—Alzheimer's disease	0.000113	0.00202	CcSEcCtD
Tapentadol—Dyspepsia—Donepezil—Alzheimer's disease	0.000113	0.00202	CcSEcCtD
Tapentadol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000112	0.00201	CcSEcCtD
Tapentadol—Shock—Rivastigmine—Alzheimer's disease	0.000112	0.002	CcSEcCtD
Tapentadol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000112	0.00199	CcSEcCtD
Tapentadol—Decreased appetite—Donepezil—Alzheimer's disease	0.000111	0.00199	CcSEcCtD
Tapentadol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000111	0.00199	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000111	0.00198	CcSEcCtD
Tapentadol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000111	0.00198	CcSEcCtD
Tapentadol—Fatigue—Donepezil—Alzheimer's disease	0.00011	0.00197	CcSEcCtD
Tapentadol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00011	0.00197	CcSEcCtD
Tapentadol—Constipation—Donepezil—Alzheimer's disease	0.00011	0.00196	CcSEcCtD
Tapentadol—Dizziness—Galantamine—Alzheimer's disease	0.000109	0.00195	CcSEcCtD
Tapentadol—Hypotension—Memantine—Alzheimer's disease	0.000109	0.00194	CcSEcCtD
Tapentadol—Hypotension—Rivastigmine—Alzheimer's disease	0.000106	0.0019	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000106	0.00189	CcSEcCtD
Tapentadol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000106	0.00189	CcSEcCtD
Tapentadol—Insomnia—Memantine—Alzheimer's disease	0.000105	0.00188	CcSEcCtD
Tapentadol—Vomiting—Galantamine—Alzheimer's disease	0.000105	0.00188	CcSEcCtD
Tapentadol—Paraesthesia—Memantine—Alzheimer's disease	0.000104	0.00187	CcSEcCtD
Tapentadol—Rash—Galantamine—Alzheimer's disease	0.000104	0.00186	CcSEcCtD
Tapentadol—Dermatitis—Galantamine—Alzheimer's disease	0.000104	0.00186	CcSEcCtD
Tapentadol—Dyspnoea—Memantine—Alzheimer's disease	0.000104	0.00185	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000104	0.00185	CcSEcCtD
Tapentadol—Headache—Galantamine—Alzheimer's disease	0.000104	0.00185	CcSEcCtD
Tapentadol—Somnolence—Memantine—Alzheimer's disease	0.000103	0.00185	CcSEcCtD
Tapentadol—Insomnia—Rivastigmine—Alzheimer's disease	0.000103	0.00184	CcSEcCtD
Tapentadol—Dyspepsia—Memantine—Alzheimer's disease	0.000102	0.00183	CcSEcCtD
Tapentadol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000102	0.00183	CcSEcCtD
Tapentadol—Urticaria—Donepezil—Alzheimer's disease	0.000102	0.00182	CcSEcCtD
Tapentadol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000101	0.00181	CcSEcCtD
Tapentadol—Somnolence—Rivastigmine—Alzheimer's disease	0.000101	0.00181	CcSEcCtD
Tapentadol—Decreased appetite—Memantine—Alzheimer's disease	0.000101	0.00181	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.0001	0.0018	CcSEcCtD
Tapentadol—Fatigue—Memantine—Alzheimer's disease	0.0001	0.00179	CcSEcCtD
Tapentadol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.0001	0.00179	CcSEcCtD
Tapentadol—Constipation—Memantine—Alzheimer's disease	9.95e-05	0.00178	CcSEcCtD
Tapentadol—Decreased appetite—Rivastigmine—Alzheimer's disease	9.89e-05	0.00177	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	9.82e-05	0.00176	CcSEcCtD
Tapentadol—Nausea—Galantamine—Alzheimer's disease	9.82e-05	0.00176	CcSEcCtD
Tapentadol—Fatigue—Rivastigmine—Alzheimer's disease	9.81e-05	0.00175	CcSEcCtD
Tapentadol—Constipation—Rivastigmine—Alzheimer's disease	9.73e-05	0.00174	CcSEcCtD
Tapentadol—Feeling abnormal—Memantine—Alzheimer's disease	9.58e-05	0.00171	CcSEcCtD
Tapentadol—CYP2D6—nervous system—Alzheimer's disease	9.46e-05	0.00661	CbGeAlD
Tapentadol—Hypersensitivity—Donepezil—Alzheimer's disease	9.44e-05	0.00169	CcSEcCtD
Tapentadol—Feeling abnormal—Rivastigmine—Alzheimer's disease	9.38e-05	0.00168	CcSEcCtD
Tapentadol—Urticaria—Memantine—Alzheimer's disease	9.24e-05	0.00165	CcSEcCtD
Tapentadol—Asthenia—Donepezil—Alzheimer's disease	9.19e-05	0.00164	CcSEcCtD
Tapentadol—CYP2D6—central nervous system—Alzheimer's disease	9.11e-05	0.00636	CbGeAlD
Tapentadol—Pruritus—Donepezil—Alzheimer's disease	9.06e-05	0.00162	CcSEcCtD
Tapentadol—Urticaria—Rivastigmine—Alzheimer's disease	9.04e-05	0.00162	CcSEcCtD
Tapentadol—CYP2D6—cerebellum—Alzheimer's disease	8.9e-05	0.00622	CbGeAlD
Tapentadol—Diarrhoea—Donepezil—Alzheimer's disease	8.76e-05	0.00157	CcSEcCtD
Tapentadol—Hypersensitivity—Memantine—Alzheimer's disease	8.57e-05	0.00153	CcSEcCtD
Tapentadol—Dizziness—Donepezil—Alzheimer's disease	8.47e-05	0.00151	CcSEcCtD
Tapentadol—Hypersensitivity—Rivastigmine—Alzheimer's disease	8.38e-05	0.0015	CcSEcCtD
Tapentadol—Asthenia—Memantine—Alzheimer's disease	8.34e-05	0.00149	CcSEcCtD
Tapentadol—Pruritus—Memantine—Alzheimer's disease	8.23e-05	0.00147	CcSEcCtD
Tapentadol—Asthenia—Rivastigmine—Alzheimer's disease	8.16e-05	0.00146	CcSEcCtD
Tapentadol—Vomiting—Donepezil—Alzheimer's disease	8.14e-05	0.00146	CcSEcCtD
Tapentadol—Rash—Donepezil—Alzheimer's disease	8.08e-05	0.00144	CcSEcCtD
Tapentadol—Dermatitis—Donepezil—Alzheimer's disease	8.07e-05	0.00144	CcSEcCtD
Tapentadol—Pruritus—Rivastigmine—Alzheimer's disease	8.05e-05	0.00144	CcSEcCtD
Tapentadol—Headache—Donepezil—Alzheimer's disease	8.02e-05	0.00143	CcSEcCtD
Tapentadol—Diarrhoea—Memantine—Alzheimer's disease	7.96e-05	0.00142	CcSEcCtD
Tapentadol—Diarrhoea—Rivastigmine—Alzheimer's disease	7.78e-05	0.00139	CcSEcCtD
Tapentadol—Dizziness—Memantine—Alzheimer's disease	7.69e-05	0.00137	CcSEcCtD
Tapentadol—Nausea—Donepezil—Alzheimer's disease	7.61e-05	0.00136	CcSEcCtD
Tapentadol—Dizziness—Rivastigmine—Alzheimer's disease	7.52e-05	0.00135	CcSEcCtD
Tapentadol—Vomiting—Memantine—Alzheimer's disease	7.39e-05	0.00132	CcSEcCtD
Tapentadol—Rash—Memantine—Alzheimer's disease	7.33e-05	0.00131	CcSEcCtD
Tapentadol—Dermatitis—Memantine—Alzheimer's disease	7.33e-05	0.00131	CcSEcCtD
Tapentadol—Headache—Memantine—Alzheimer's disease	7.29e-05	0.0013	CcSEcCtD
Tapentadol—Vomiting—Rivastigmine—Alzheimer's disease	7.23e-05	0.00129	CcSEcCtD
Tapentadol—CYP2D6—brain—Alzheimer's disease	7.23e-05	0.00505	CbGeAlD
Tapentadol—Rash—Rivastigmine—Alzheimer's disease	7.17e-05	0.00128	CcSEcCtD
Tapentadol—Dermatitis—Rivastigmine—Alzheimer's disease	7.17e-05	0.00128	CcSEcCtD
Tapentadol—Headache—Rivastigmine—Alzheimer's disease	7.13e-05	0.00127	CcSEcCtD
Tapentadol—Nausea—Memantine—Alzheimer's disease	6.91e-05	0.00124	CcSEcCtD
Tapentadol—Nausea—Rivastigmine—Alzheimer's disease	6.76e-05	0.00121	CcSEcCtD
Tapentadol—OPRK1—Signaling Pathways—NTRK2—Alzheimer's disease	5.48e-06	0.000276	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CALM1—Alzheimer's disease	5.45e-06	0.000274	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.44e-06	0.000274	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ND1—Alzheimer's disease	5.43e-06	0.000273	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GSK3A—Alzheimer's disease	5.43e-06	0.000273	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NGFR—Alzheimer's disease	5.36e-06	0.00027	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARGC1A—Alzheimer's disease	5.35e-06	0.000269	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APP—Alzheimer's disease	5.34e-06	0.000269	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	5.33e-06	0.000268	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—HMOX1—Alzheimer's disease	5.33e-06	0.000268	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.32e-06	0.000268	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CREB1—Alzheimer's disease	5.32e-06	0.000268	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.31e-06	0.000267	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPY—Alzheimer's disease	5.3e-06	0.000267	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IAPP—Alzheimer's disease	5.27e-06	0.000265	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ADAM10—Alzheimer's disease	5.23e-06	0.000263	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL2—Alzheimer's disease	5.21e-06	0.000262	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PLCB1—Alzheimer's disease	5.2e-06	0.000262	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—F2—Alzheimer's disease	5.12e-06	0.000258	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CRH—Alzheimer's disease	5.12e-06	0.000258	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.1e-06	0.000257	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR5—Alzheimer's disease	5.05e-06	0.000254	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ABCA1—Alzheimer's disease	5.04e-06	0.000254	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PLCB1—Alzheimer's disease	5.03e-06	0.000253	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—S100B—Alzheimer's disease	4.95e-06	0.000249	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	4.94e-06	0.000249	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—LPL—Alzheimer's disease	4.87e-06	0.000245	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.85e-06	0.000244	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPS—Alzheimer's disease	4.85e-06	0.000244	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	4.83e-06	0.000243	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—F2—Alzheimer's disease	4.77e-06	0.00024	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTK2B—Alzheimer's disease	4.76e-06	0.000239	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IGF2—Alzheimer's disease	4.71e-06	0.000237	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NGFR—Alzheimer's disease	4.7e-06	0.000236	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CREB1—Alzheimer's disease	4.67e-06	0.000235	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NTRK2—Alzheimer's disease	4.63e-06	0.000233	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GAB2—Alzheimer's disease	4.63e-06	0.000233	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SST—Alzheimer's disease	4.63e-06	0.000233	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CALM1—Alzheimer's disease	4.61e-06	0.000232	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ADAM10—Alzheimer's disease	4.59e-06	0.000231	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.59e-06	0.000231	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GSK3A—Alzheimer's disease	4.59e-06	0.000231	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL2—Alzheimer's disease	4.57e-06	0.00023	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IGF1R—Alzheimer's disease	4.56e-06	0.000229	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APP—Alzheimer's disease	4.51e-06	0.000227	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MTHFR—Alzheimer's disease	4.39e-06	0.000221	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—LPL—Alzheimer's disease	4.37e-06	0.00022	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARGC1A—Alzheimer's disease	4.35e-06	0.000219	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—S100B—Alzheimer's disease	4.34e-06	0.000218	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—F2—Alzheimer's disease	4.33e-06	0.000218	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MEF2C—Alzheimer's disease	4.33e-06	0.000218	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—HMOX1—Alzheimer's disease	4.33e-06	0.000218	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PLCB1—Alzheimer's disease	4.26e-06	0.000214	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PRKCG—Alzheimer's disease	4.25e-06	0.000214	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.18e-06	0.000211	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.18e-06	0.00021	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NGF—Alzheimer's disease	4.14e-06	0.000208	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF2—Alzheimer's disease	4.13e-06	0.000208	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CALM1—Alzheimer's disease	4.1e-06	0.000206	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOE—Alzheimer's disease	4.08e-06	0.000205	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CAV1—Alzheimer's disease	4.05e-06	0.000204	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR5—Alzheimer's disease	4.02e-06	0.000202	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF1R—Alzheimer's disease	3.99e-06	0.000201	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NGFR—Alzheimer's disease	3.97e-06	0.0002	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—LPL—Alzheimer's disease	3.96e-06	0.000199	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CREB1—Alzheimer's disease	3.95e-06	0.000199	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2A—Alzheimer's disease	3.94e-06	0.000198	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADAM10—Alzheimer's disease	3.88e-06	0.000195	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL2—Alzheimer's disease	3.86e-06	0.000194	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TPI1—Alzheimer's disease	3.84e-06	0.000193	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CHAT—Alzheimer's disease	3.84e-06	0.000193	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LPL—Alzheimer's disease	3.83e-06	0.000193	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.81e-06	0.000192	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MEF2C—Alzheimer's disease	3.8e-06	0.000191	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PRKCG—Alzheimer's disease	3.72e-06	0.000187	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MAOB—Alzheimer's disease	3.68e-06	0.000185	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CALM1—Alzheimer's disease	3.67e-06	0.000185	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—S100B—Alzheimer's disease	3.67e-06	0.000185	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—LEP—Alzheimer's disease	3.66e-06	0.000184	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOE—Alzheimer's disease	3.66e-06	0.000184	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NGF—Alzheimer's disease	3.63e-06	0.000183	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CAV1—Alzheimer's disease	3.63e-06	0.000183	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MTHFR—Alzheimer's disease	3.56e-06	0.000179	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARG—Alzheimer's disease	3.56e-06	0.000179	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	3.54e-06	0.000178	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	3.53e-06	0.000178	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	3.53e-06	0.000178	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR5—Alzheimer's disease	3.53e-06	0.000178	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.5e-06	0.000176	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CHAT—Alzheimer's disease	3.5e-06	0.000176	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TPI1—Alzheimer's disease	3.5e-06	0.000176	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ESR1—Alzheimer's disease	3.49e-06	0.000176	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	3.49e-06	0.000176	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—INS—Alzheimer's disease	3.49e-06	0.000176	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.47e-06	0.000175	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2A—Alzheimer's disease	3.45e-06	0.000174	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—F2—Alzheimer's disease	3.45e-06	0.000174	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—A2M—Alzheimer's disease	3.42e-06	0.000172	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	3.38e-06	0.00017	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.38e-06	0.00017	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	3.38e-06	0.00017	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MAOB—Alzheimer's disease	3.35e-06	0.000169	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CALM1—Alzheimer's disease	3.33e-06	0.000168	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOE—Alzheimer's disease	3.32e-06	0.000167	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CAV1—Alzheimer's disease	3.29e-06	0.000165	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	3.26e-06	0.000164	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	3.24e-06	0.000163	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	3.23e-06	0.000163	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CALM1—Alzheimer's disease	3.22e-06	0.000162	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LEP—Alzheimer's disease	3.21e-06	0.000162	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOE—Alzheimer's disease	3.21e-06	0.000162	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	3.21e-06	0.000161	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.19e-06	0.000161	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CAV1—Alzheimer's disease	3.18e-06	0.00016	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GSK3B—Alzheimer's disease	3.17e-06	0.00016	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.16e-06	0.000159	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	3.15e-06	0.000158	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—A2M—Alzheimer's disease	3.15e-06	0.000158	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CREB1—Alzheimer's disease	3.14e-06	0.000158	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—INS—Alzheimer's disease	3.13e-06	0.000157	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—A2M—Alzheimer's disease	3.12e-06	0.000157	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL2—Alzheimer's disease	3.08e-06	0.000155	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	3.07e-06	0.000154	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ESR1—Alzheimer's disease	3.06e-06	0.000154	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—NOS3—Alzheimer's disease	3.06e-06	0.000154	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.05e-06	0.000153	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—F2—Alzheimer's disease	3.03e-06	0.000152	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IGF1—Alzheimer's disease	3.02e-06	0.000152	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	2.98e-06	0.00015	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ACHE—Alzheimer's disease	2.98e-06	0.00015	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.96e-06	0.000149	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	2.94e-06	0.000148	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	2.92e-06	0.000147	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARG—Alzheimer's disease	2.89e-06	0.000145	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—INS—Alzheimer's disease	2.83e-06	0.000143	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—Alzheimer's disease	2.8e-06	0.000141	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ENO1—Alzheimer's disease	2.79e-06	0.00014	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	2.79e-06	0.00014	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.78e-06	0.00014	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GSK3B—Alzheimer's disease	2.78e-06	0.00014	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CREB1—Alzheimer's disease	2.76e-06	0.000139	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOS3—Alzheimer's disease	2.74e-06	0.000138	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—INS—Alzheimer's disease	2.74e-06	0.000138	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	2.74e-06	0.000138	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	2.73e-06	0.000138	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	2.72e-06	0.000137	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ACHE—Alzheimer's disease	2.71e-06	0.000137	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	2.71e-06	0.000137	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	2.71e-06	0.000137	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	2.71e-06	0.000136	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL2—Alzheimer's disease	2.7e-06	0.000136	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	2.69e-06	0.000135	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	2.68e-06	0.000135	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF1—Alzheimer's disease	2.65e-06	0.000133	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—BCHE—Alzheimer's disease	2.59e-06	0.00013	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	2.59e-06	0.00013	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	2.56e-06	0.000129	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	2.56e-06	0.000129	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—F2—Alzheimer's disease	2.56e-06	0.000129	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ENO1—Alzheimer's disease	2.54e-06	0.000128	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	2.54e-06	0.000128	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.5e-06	0.000126	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	2.49e-06	0.000125	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NOS3—Alzheimer's disease	2.49e-06	0.000125	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	2.45e-06	0.000123	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOS3—Alzheimer's disease	2.4e-06	0.000121	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.4e-06	0.000121	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	2.38e-06	0.00012	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	2.37e-06	0.000119	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—BCHE—Alzheimer's disease	2.36e-06	0.000119	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.35e-06	0.000118	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	2.35e-06	0.000118	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	2.33e-06	0.000117	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CASP3—Alzheimer's disease	2.33e-06	0.000117	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—INS—Alzheimer's disease	2.32e-06	0.000117	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—Alzheimer's disease	2.31e-06	0.000116	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	2.28e-06	0.000115	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—Alzheimer's disease	2.27e-06	0.000114	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	2.25e-06	0.000113	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.24e-06	0.000113	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	2.23e-06	0.000112	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.19e-06	0.00011	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	2.18e-06	0.00011	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	2.16e-06	0.000109	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MAPK8—Alzheimer's disease	2.14e-06	0.000108	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—AKT1—Alzheimer's disease	2.13e-06	0.000107	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.06e-06	0.000104	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	2.04e-06	0.000103	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	2.04e-06	0.000103	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	2.03e-06	0.000102	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.03e-06	0.000102	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	2.03e-06	0.000102	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.98e-06	9.94e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	1.88e-06	9.46e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	1.88e-06	9.44e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	1.87e-06	9.42e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	1.87e-06	9.41e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.86e-06	9.38e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LPL—Alzheimer's disease	1.86e-06	9.36e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.85e-06	9.33e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.81e-06	9.13e-05	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.74e-06	8.76e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	1.73e-06	8.72e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.73e-06	8.68e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.71e-06	8.63e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LPL—Alzheimer's disease	1.71e-06	8.61e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.7e-06	8.54e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	1.67e-06	8.43e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	1.59e-06	8e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.59e-06	7.98e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.58e-06	7.96e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CALM1—Alzheimer's disease	1.56e-06	7.88e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOE—Alzheimer's disease	1.56e-06	7.85e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.55e-06	7.78e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.54e-06	7.75e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.53e-06	7.69e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	1.49e-06	7.51e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.46e-06	7.37e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.44e-06	7.24e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.43e-06	7.22e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.43e-06	7.18e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.42e-06	7.16e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.42e-06	7.15e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.41e-06	7.09e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—AKT1—Alzheimer's disease	1.41e-06	7.08e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	1.37e-06	6.88e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.36e-06	6.84e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.34e-06	6.76e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—INS—Alzheimer's disease	1.33e-06	6.7e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	1.31e-06	6.59e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.26e-06	6.34e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.25e-06	6.29e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.24e-06	6.23e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—INS—Alzheimer's disease	1.23e-06	6.17e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—INS—Alzheimer's disease	1.21e-06	6.11e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	1.2e-06	6.03e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.17e-06	5.88e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—AKT1—Alzheimer's disease	1.14e-06	5.75e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	1.11e-06	5.57e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	1.11e-06	5.56e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.07e-06	5.41e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.07e-06	5.38e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.07e-06	5.36e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	1.01e-06	5.1e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	9.83e-07	4.95e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	9.74e-07	4.9e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	9.34e-07	4.7e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKT1—Alzheimer's disease	5.37e-07	2.7e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	4.94e-07	2.49e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKT1—Alzheimer's disease	4.9e-07	2.46e-05	CbGpPWpGaD
